Implementation of a Market Entry Reward within the United States.

Published

Journal Article

As part of a multifactorial approach to address weak incentives for innovative antimicrobial drug development, market entry rewards (MERs) are an emerging solution. Recently, the Duke-Margolis Center for Health Policy released the Priority Antimicrobial Value and Entry (PAVE) Award proposal, which combines a MER with payment reforms, transitioning from volume-based to "value-based" payments for antimicrobials. Here, the PAVE Award and similar MERs are reviewed, focusing on further refinement and avenues for implementation.

Full Text

Duke Authors

Cited Authors

  • Daniel, GW; Schneider, M; Lopez, MH; McClellan, MB

Published Date

  • June 2018

Published In

Volume / Issue

  • 46 / 1_suppl

Start / End Page

  • 50 - 58

PubMed ID

  • 30146957

Pubmed Central ID

  • 30146957

Electronic International Standard Serial Number (EISSN)

  • 1748-720X

International Standard Serial Number (ISSN)

  • 1073-1105

Digital Object Identifier (DOI)

  • 10.1177/1073110518782915

Language

  • eng